Related to Gene Therapy Society Looking to NIH to Revisit Role of the Recombinant DNA Advisory Committee

• Point of View: Designing Improved Humans
  
• Point of View: Defending Pharma Companies
  
• BioMarket Trends: Securing a Slice of NIH Stimulus Funding
  
• Feature Articles: Pioneering New Collaborative Approaches
  
• Feature Articles: Tips on Expediting Cell-Line Development
  
• Feature Articles: Team CF and Racing on the Road for a Cure
  
• Tutorials: Optimizing Downstream Processing of Enveloped Viruses
  
• Feature Articles: Gene Delivery on a Rebound
  
• Feature Articles: Status of Cell and Gene Therapy Keeps Vacillating
  
• Point of View: NIH Pharma Co. Is a Bad Idea
  
• Point of View: NCATS Could Mitigate Pharma Valley of Death
  
• Point of View: Revamping Research Funding
  
• Point of View: T-Cell Therapy Eradicates CLL in Trial
  
• Feature Articles: The History and Promise of Gene Therapy
  
• Point of View: Driving Down Medical and Healthcare Spending